What is Daurismo (glasdegib) for?
Daurismo (glasdegib) is a hedgehog pathway inhibitor indicated, in combination with low-dose chemotherapy (cytarabine), to treat newly diagnosed acute myeloid leukemia (AML) in adults who are 75 years of age or older, or have other medical conditions that prevent the use of standard chemotherapy.
It is available in tablet form, each containing either 25 mg or 100 mg glasdegib.
How does Daurismo (glasdegib) work?
The active ingredient in Daurismo, glasdegib, can block the protein ‘SMO’. In people where SMO is not working normally, cancer cells can grow uncontrollably and cancer medicines stop having effect. By inhibiting SMO, the ability of cancer cells to survive and grow is reduced, while cancer treatment becomes more effective.
Daurismo is given together with chemotherapy. Chemotherapy can kill cancer cells, but some cells may “hide” and escape from chemotherapy. Some cancer cells may remain after treatment and can survive and grow further. Daurismo is thought to help chemotherapy destroy cancer cells and stop the growth of the tumor. Buy Now With Ease.